Anzeige
Mehr »
Login
Samstag, 18.09.2021 Börsentäglich über 12.000 News von 675 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QLBW ISIN: US00484M6012 Ticker-Symbol: CDG0 
Tradegate
16.09.21
18:09 Uhr
3,980 Euro
+0,040
+1,02 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ACORDA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
ACORDA THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,0404,08017.09.
3,9804,10017.09.

Aktuelle News zur ACORDA THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.09.Acorda slashes jobs again as generics hamper sales of MS drug1
09.09.Struggling Acorda team brings out the axe - yet again - to chop away at costs as sales sputter3
09.09.Acorda Therapeutics To Reduce Headcount; Names Lauren Sabella COO1
ACORDA THERAPEUTICS Aktie jetzt für 0€ handeln
09.09.ACORDA THERAPEUTICS INC - 8-K, Current Report1
09.08.Acorda Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation6
08.08.Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2021 Results - Earnings Call Transcript5
05.08.Acorda Therapeutics EPS misses by $0.20, beats on revenue5
24.07.Acorda Therapeutics Continues To Maneuver For A Turnaround22
23.07.ACORDA THERAPEUTICS INC - 8-K, Current Report11
23.07.The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs20
22.07.Acorda Therapeutics, Inc.: Acorda Therapeutics Announces Agreement to Commercialize INBRIJA in Spain470Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has entered into distribution and supply agreements with Esteve Pharmaceuticals S.A (ESTEVE) to commercialize INBRIJA 33 mg (levodopa...
► Artikel lesen
19.06.Hedge Funds Are Buying Acorda Therapeutics Inc (ACOR) Again15
16.06.ACORDA THERAPEUTICS INC - 8-K, Current Report5
16.06.Acorda Therapeutics to repay convertible senior notes3
02.06.ACORDA THERAPEUTICS INC - 8-K, Current Report3
12.05.ACORDA THERAPEUTICS INC - 10-Q, Quaterly Report7
09.05.Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q1 2021 Results - Earnings Call Transcript6
30.04.Acorda Therapeutics: Buying Before The Coast Is Clear15
21.04.Aesthetic Medical International, Acorda Therapeutics leads healthcare gainers; Atea Pharmaceuticals, Inotiv among major losers9
14.01.Acorda Rises On Restructuring, ALXN Pauses COVID-19 Trial, SYBX On Watch2.003WASHINGTON (dpa-AFX) - Today's Daily Dose brings you news about Acorda's restructuring; Alexion's decision to pause its COVID-19 trial; and analyst's rating on Synlogic.Read on.1. Acorda Rises...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1